Graafsma et al reported criteria for grading anticoagulant-related bleeding as well as a bleeding severity index. The authors are from the University of Amsterdam and University Hospital Leiden, the Netherlands.
Clinical Findings |
Bleeding |
---|---|
no evidence of unusual bleeding |
no bleeding |
clinically overt bleeding but no criteria for major bleeding met |
minor bleeding |
one or more criteria for major bleeding (see below) |
major bleeding |
Criteria for major bleeding - one or more of the following:
(1) fall in hemoglobin by >= 2 g/dL
(2) requiring transfusion of 2 or more units of packed RBCs
(3) retroperitoneal or intracranial bleeding
(4) severe enough to warrant discontinuation of anticoagulant therapy
Bleeding Severity |
Therapy |
Index |
---|---|---|
insufficient information to classify |
NA |
7 |
no bleeding |
none |
6 |
minor |
none |
5 |
mild |
requires medical examination but no intervention |
4 |
moderate |
requires medical examination and intervention but not hospitalized |
3 |
moderate to severe |
hospitalized |
2 |
fatal or life-threatening |
intensive care |
1 |
Purpose: To evaluate bleeding in a patient being treated with an anticoagulant using the criteria of Graafsma et al.
Specialty: Hematology Oncology, Clinical Laboratory, Pharmacology, clinical
Objective: criteria for diagnosis, severity, prognosis, stage
ICD-10: R58,